Aethlon Medical Files 8‑K Reporting Results of Operations (Aug 13, 2026)

What Happened

• Aethlon Medical, Inc. (AEMD) filed a Current Report on Form 8-K on August 13, 2026 to report its results of operations and financial condition (Item 2.02). The company also provided a Regulation FD disclosure (Item 7.01) and furnished a press release dated August 13, 2026 as an exhibit to the filing.
• The press release (Exhibit 99.1) is the public vehicle for the financial update; the 8-K incorporates that information by reference so investors can find the detailed figures in the press release.

Key Details

• Filing date: August 13, 2026 (Form 8-K, accession 0001683168-26-006344).
• Reported items: Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure).
• Exhibit filed: 99.1 — press release dated August 13, 2026 (and interactive XBRL cover page, Exhibit 104).
• The 8-K furnishes the company’s public disclosure of financial results; specific revenue, profit/loss, cash balance, or guidance figures are contained in the attached press release.

Why It Matters

• This filing provides updated, material financial information directly from Aethlon; such reports can affect investor assessments of the company's recent performance and near-term prospects.
• Regulation FD disclosure means the company distributed the information publicly to ensure all investors have access at the same time. Retail investors should read the attached press release for the exact earnings, revenue, and cash position details before making decisions.